Annals of Hepatology (Sep 2021)

P-53 FAILURE IN ALL STEPS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE PROCESS IS FREQUENT IN DAILY PRACTICE.

  • Melisa Dirchwolf,
  • Sebastián Marciano,
  • Andres E. Ruf,
  • Amit G. Singal,
  • Vanina D'Ercole,
  • Paola Coisson,
  • Alina Zerega,
  • Federico Orozco,
  • Ana Palazzo,
  • Eduardo Fassio,
  • Diego Arufe,
  • Margarita Anders,
  • Claudia D'Amico,
  • Luis Gaite,
  • Marcos Thompson,
  • Daniela Perez,
  • Leila Haddad,
  • Ezequiel Demirdjian,
  • Moira Zunino,
  • Adrián Gadano,
  • María Dolores Murga,
  • Carla Bermudez,
  • Jesica Tomatis,
  • Nadia Grigera,
  • Florencia Antinucci,
  • Manuel Baravalle,
  • Maria Mercedes Rodriguez Gazari,
  • Melina Ferreiro,
  • Manuel Barbero,
  • Andrea Curia,
  • Manuel Demonte,
  • Gisela Gualano

Journal volume & issue
Vol. 24
p. 100417

Abstract

Read online

Introduction: Failures at any step in the hepatocellular carcinoma (HCC) surveillance process can result in HCC diagnostic delays and associated worse prognosis. Objectives: We aimed to estimate the prevalence of surveillance failure and its associated risk factors in patients with HCC in Argentina, considering three steps: 1) recognition of at-risk patients, 2) implementation of HCC surveillance, 3) success of HCC surveillance. Methods: We performed a multi-center cross-sectional study of patients at-risk for HCC in Argentina seen between10.01.2018 and 10.30.2019. Multivariable logistic regression analysis was used to identify correlates of surveillance failure. Results: Of 301 included patients, the majority were male (74.8%) with a mean age of 64 years old. At the time of HCC diagnosis, 75 (24.9%) patients were unaware of their diagnosis of chronic liver disease, and only 130 (43.2%) patients were under HCC surveillance. Receipt of HCC surveillance was significantly associated with follow-up by a hepatologist. Of 119 patients with complete surveillance, surveillance failure occurred in 30 (25.2%) patients. Patients under complete surveillance were significantly more likely to be diagnosed within Milan criteria than those without surveillance (75% vs. 50%, p<0.001),(Figure). Surveillance failure was significantly associated with alpha fetoprotein ≥20 ng/ml (OR 4.0, CI 95% 1.43-11.55). Conclusions: HCC surveillance failure was frequent in all the evaluated steps. These data should help guide strategies to improve the implementation and results of HCC surveillance in our country.